Quercetin as a novel activator of L-type Ca 2+ channels in rat tail artery smooth muscle cells

British Journal of Pharmacology

Volumn 135, Issue 7, 2002, Pages 1819-1827

  Saponara, Simona ^a   Sgaragli, Giampietro ^a   Fusi, Fabio ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

L type Ca 2+ channel activator; Muscle cell patch clamp; Quercetin; Rat tail artery smooth muscle

Indexed keywords

AMPHOTERICIN B; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL STIMULATING AGENT; CALCIUM CHANNEL T TYPE; QUERCETIN;

ANIMAL CELL; ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; CALCIUM CURRENT; CHANNEL GATING; CONTROLLED STUDY; ELECTRIC POTENTIAL; EQUILIBRIUM CONSTANT; HYPERPOLARIZATION; ION CURRENT; ISOLATED ARTERY; MALE; MEMBRANE POTENTIAL; MEMBRANE STEADY POTENTIAL; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; TAIL ARTERY;

ANIMALS; CALCIUM CHANNELS, L-TYPE; ELECTROPHYSIOLOGY; KINETICS; MALE; MUSCLE, SMOOTH, VASCULAR; PATCH-CLAMP TECHNIQUES; QUERCETIN; RATS; TAIL;

EID: 0036968559     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704631     Document Type: Article

References (40)

1. BOLTON, T.B., AARONSON, P.I. & MACKENZIE, I. (1988). Voltage-dependent calcium channel in intestinal and vascular smooth muscle cells. Ann. N.Y. Acad. Sci., 522, 32-42.
2. BRAVO, L. (1998). Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr. Rev., 56, 317-333.
3. CAMPBELL, D.L., STAMLER, J.S. & STRAUSS, H.C. (1996). Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols. J. Gen. Physiol., 108, 277-293.
4. DAY, A.J. & WILLIAMSON, G. (2001). Biomarkers for exposure to dietary falvonoids: a review of the current evidence for identification of quercetin glycosides in plasma. Br. J. Nutr., 86, 105-110.
5. DUARTE, J., PEREZ-PALENCIA, R., VARGAS, F., OCETE, M.A., PEREZ-VIZCAINO, F., ZARZUELO, A. & TAMARGO, J. (2001). Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Br. J. Pharmacol., 133, 117-124.
6. DUARTE, J., PEREZ-VIZCAINO, F., ZARZUELO, A., JIMENEZ, J. & TAMARGO, J. (1993). Vasodilator effects of quercetin in isolated rat vascular smooth muscle. Eur. J. Pharmacol., 239, 1-7.
7. ERLUND, I., KOSONEN, T., ALFTHAN, G., MAENPAA, J., PERTTUNEN, K., KENRAALI, J., PARANTAINEN, J. &, ARO, A. (2000). Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. Eur. J. Clin. Pharmacol., 56, 545-553.
8. FERRIOLA, P.C., CODY, V. & MIDDLETON, E. (1989). Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem. Pharmacol., 38, 1617-1624.
9. FORMICA, J.V. & REGELSON, W. (1995). Review of the biology of quercetin and related bioflavonoids. Food Chem. Toxicol., 33, 1061-1080.
10. 2+ current of guinea-pig gastric fundus smooth muscle. Br. J. Pharmacol., 132, 1326-1332.
11. 2+ channel via superoxide anion generation. Br. J. Pharmacol., 133, 988-996.
12. GRAEFE, E.U., WITTIG, J., MUELLER, S., RIETHLING, A.K., UEHLEKE, B., DREWELOW, B., PFORTE, H., JACOBASCH, G., DERENDORF, H. & VEIT, M. (2001). Pharmacokinetics and bioavailability of quercetin glycosides in humans. J. Clin. Pharmacol., 41, 492-499.
13. HAMILL, O.P., MARTY, A., NEHER, E., SAKMANN, B. & SIGWORTH, F.J. (1981). Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch., 391, 85-100.
14. HAMILTON, S.L. & PEREZ, M. (1987). Toxins that affect voltage-dependent calcium channels. Biochem. Pharmacol., 36, 3325-3329.
15. HERTOG, M.G., FESKENS, E.J., HOLLMAN, P.C., KATAN, M.B. & KROMHOUT, D. (1993). Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet, 342, 1007-1011.
16. HERTOG, M.G., KROMHOUT, D., ARAVANIS, C., BLACKBURN, H., BUZINA, R., FIDANZA, F., GIAMPAOLI, S., JANSEN, A., MENOTTI, A., NEDELJKOVIC, S., PEKKARINEN, M., SIMIC, B.S., TOSHIMA, H., FESKENS, E.J.M., HOLLMAN, P.C.H. & KATAN, M.B. (1995). Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch. Intern. Med., 155, 381-386.
17. HESS, P., LANSMAN, J.B. & TSIEN, R.W. (1984). Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists. Nature, 311, 538-544.
18. HOLLMAN, P.C., VAN TRIJP, J.M., BUYSMAN, M.N., VAN DER GAAG, M.S., MENGELERS, M.J., DE VRIES, J.H. & KATAN, M.B. (1997). Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett., 418, 152-156.
19. 2+ channels. Evidence for an agonistic action. J. Biol. Chem., 265, 1156-1166.
20. KOKUBUN, S. & REUTER, H. (1984). Dihydropyridine derivatives prolong the open state of Ca channels in cultured cardiac cells. Proc. Natl. Acad. Sci. U.S.A., 81, 4824-4827.
21. NIKAIDO, T., OHMOTO, T., SANKAWA, U., HAMANAKA, T. & TOTSUKA, K. (1982). Inhibition of cyclic AMP phosphodiesterase by flavonoids. Planta Med., 46, 162-166.
22. OLTHOF, M.R., HOLLMAN, P.C., VREE, T.B. & KATAN, M.B. (2000). Bioavailabilities of quercetin-3-glucoside and quercetin-4′-glucoside do not differ in humans. J. Nutr., 130, 1200-1203.
23. ORGOGOZO, J.M., DARTIGUES, J.F., LAFONT, S., LETENNEUR, L., COMMENGES, D., SALAMON, R., RENAUD, S. & BRETELER, M.B. (1997). Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev. Neurol., 153, 185-192.
24. PATMORE, L., DUNCAN, G.P., CLARKE, B., ANDERSON, A.J., GREENHOUSE, R. & PFISTER, J.R. (1990). RS 30026: a potent and effective calcium channel agonist. Br. J. Pharmacol., 99, 687-694.
25. PETKOV, G.V., FUSI, F., SAPONARA, S., GAGOV, H., SGARAGLI, G.P. & BOEV, K.K. (2001). Characterization of voltage-gated calcium currents in freshly isolated smooth muscle cells from rat tail main artery. Acta Physiol. Scand., 173, 257-265.
26. RAE, J., COOPER, K., GATES, P. & WATSKY, M. (1991). Low access resistance perforated patch recordings using amphotericin B. J. Neurosci. Methods, 37, 15-26.
27. RAMPE, D. & LACERDA, A.E. (1991). A new site for the activation of cardiac calcium channels defined by the nondihydropyridine FPL 64176. J. Pharmacol. Exp. Ther., 259, 982-987.
28. RASMUSSEN, H., TAKUWA, Y. & PARK, S. (1987). Protein kinase C in the regulation of smooth muscle contraction. FASEB J., 3, 177-185.
29. RENAUD, S.C., GUEGUEN, R., SCHENKER, J. & D'HOUTAUD, A. (1998). Alcohol and mortality in middle-aged men from eastern France. Epidemiology, 9, 184-188.
30. RENAUD, S.C., GUEGUEN, R., SIEST, G. & SALAMON, R. (1999). Wine, beer, and mortality in middle-aged men from eastern France. Arch. Intern. Med., 159, 1865-1870.
31. RICE-EVANS, C.A., MILLER, N.J. & PAGANGA, G. (1996). Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med., 20, 933-956.
32. SAPONARA, S., FUSI, F., PESSINA, F., GORELLI, B., VITTORI, L. & SGARAGLI, G.P. (2001). Effects of quercetin on vascular smooth muscle. Pharmacol. Res., 43 (suppl A): 24.
33. SGARAGLI, G.P., VALOTI, M., GORELLI, B., FUSI, F., PALMI, M. & MANTOVANI, P. (1993). Calcium antagonist and antiperoxidant properties of some hindered phenols. Br. J. Pharmacol., 110, 369-377.
34. STANSFELD, C. & MATHIE, A. (1993). Recording membrane currents of peripheral neurones in short-term culture. In Electrophysiology. A practical approach. ed. Wallis, D.I. pp. 3-28. Oxford: IRL Press.
35. 1 cells. Eur. J. Pharmacol., 414, 125-133.
36. VISENTIN, S., AMIEL, P., FRUTTERO, R., BOSCHI, D., ROUSSEL, C., GIUSTA, L., CARBONE, E. & GASCO, A. (1999). Synthesis and voltage-clamp studies of methyl 1,4-dihydro-2,6-dimethyl-5-nitro-4-(benzofurazanyl)pyridine-3-carboxylate racemates and enantiomers and of their benzofuroxanyl analogues. J. Med. Chem., 42, 1422-1427.
37. WANG, R., KARPINSKI, E. & PANG, P.K. (1989). Two types of calcium channels in isolated smooth muscle cells from rat tail artery. Am. J. Physiol., 256, H1361-H1368.
38. WOLIN, M.S. (2000). Interactions of oxidants with vascular signaling systems. Arterioscler. Thromb. Vasc. Biol., 20, 1430-1442.
39. XIONG, Z. & SPERELAKIS, N. (1995). Regulation of L-type calcium channels of vascular smooth muscle cells. J. Mol. Cell. Cardiol., 27, 75-91.
40. 2+ channel activator, in cardiac and vascular preparations. Mol. Pharmacol., 40, 734-741.